ArticleInternational journal of pharmaceutics2023

Targeting β-catenin using XAV939 nanoparticle promotes immunogenic cell death and suppresses conjunctival melanoma progression.

Ferrin Antony et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.